186 related articles for article (PubMed ID: 32265897)
1. NGS Evaluation of Colorectal Cancer Reveals Interferon Gamma Dependent Expression of Immune Checkpoint Genes and Identification of Novel IFNγ Induced Genes.
Xu L; Pelosof L; Wang R; McFarland HI; Wu WW; Phue JN; Lee CT; Shen RF; Juhl H; Wu LH; Alterovitz WL; Petricon E; Rosenberg AS
Front Immunol; 2020; 11():224. PubMed ID: 32265897
[TBL] [Abstract][Full Text] [Related]
2. High expression of immune checkpoints is associated with the TIL load, mutation rate and patient survival in colorectal cancer.
Kitsou M; Ayiomamitis GD; Zaravinos A
Int J Oncol; 2020 Jul; 57(1):237-248. PubMed ID: 32468013
[TBL] [Abstract][Full Text] [Related]
3. Development of an IFNγ response-related signature for predicting the survival of cutaneous melanoma.
Hu B; Wei Q; Li X; Ju M; Wang L; Zhou C; Chen L; Li Z; Wei M; He M; Zhao L
Cancer Med; 2020 Nov; 9(21):8186-8201. PubMed ID: 32902917
[TBL] [Abstract][Full Text] [Related]
4. IFI30 as a key regulator of PDL1 immunotherapy prognosis in breast cancer.
Li L; Fei Y; Dong T; Song Y; Chen X; Zhang H; Zhou H; Liang M; Tang J
Int Immunopharmacol; 2024 May; 133():112093. PubMed ID: 38669947
[TBL] [Abstract][Full Text] [Related]
5. IFI30 expression predicts patient prognosis in breast cancer and dictates breast cancer cells proliferation via regulating autophagy.
Fan Y; Wang X; Li Y
Int J Med Sci; 2021; 18(14):3342-3352. PubMed ID: 34400904
[No Abstract] [Full Text] [Related]
6. Intratumoral injection of interferon gamma promotes the efficacy of anti-PD1 treatment in colorectal cancer.
Tang Y; Wei J; Ge X; Yu C; Lu W; Qian Y; Yang H; Fu D; Fang Y; Zhou X; Wang Z; Xiao Q; Ding K
Cancer Lett; 2024 Apr; 588():216798. PubMed ID: 38467181
[TBL] [Abstract][Full Text] [Related]
7. Immune Checkpoint Protein Expression Defines the Prognosis of Advanced Thyroid Carcinoma.
Luo Y; Yang YC; Shen CK; Ma B; Xu WB; Wang QF; Zhang Y; Liao T; Wei WJ; Wang Y
Front Endocrinol (Lausanne); 2022; 13():859013. PubMed ID: 35574031
[TBL] [Abstract][Full Text] [Related]
8. Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer.
Zaravinos A; Roufas C; Nagara M; de Lucas Moreno B; Oblovatskaya M; Efstathiades C; Dimopoulos C; Ayiomamitis GD
J Exp Clin Cancer Res; 2019 Aug; 38(1):364. PubMed ID: 31429779
[TBL] [Abstract][Full Text] [Related]
9. 9-Gene Signature Correlated With CD8
Yan K; Lu Y; Yan Z; Wang Y
Front Immunol; 2021; 12():622563. PubMed ID: 34220795
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of immune checkpoint molecules in breast cancer.
Fang J; Chen F; Liu D; Gu F; Chen Z; Wang Y
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32602545
[TBL] [Abstract][Full Text] [Related]
11. Distinct prognostic value of mRNA expression of guanylate-binding protein genes in skin cutaneous melanoma.
Wang Q; Wang X; Liang Q; Wang S; Xiwen L; Pan F; Chen H; Li D
Oncol Lett; 2018 May; 15(5):7914-7922. PubMed ID: 29725478
[TBL] [Abstract][Full Text] [Related]
12. Phospho‑STAT1 expression as a potential biomarker for anti‑PD‑1/anti‑PD‑L1 immunotherapy for breast cancer.
Nakayama Y; Mimura K; Tamaki T; Shiraishi K; Kua LF; Koh V; Ohmori M; Kimura A; Inoue S; Okayama H; Suzuki Y; Nakazawa T; Ichikawa D; Kono K
Int J Oncol; 2019 Jun; 54(6):2030-2038. PubMed ID: 31081058
[TBL] [Abstract][Full Text] [Related]
13. Guanylate-Binding Protein 1: An Emerging Target in Inflammation and Cancer.
Honkala AT; Tailor D; Malhotra SV
Front Immunol; 2019; 10():3139. PubMed ID: 32117203
[TBL] [Abstract][Full Text] [Related]
14. Cytolytic Activity Score to Assess Anticancer Immunity in Colorectal Cancer.
Narayanan S; Kawaguchi T; Yan L; Peng X; Qi Q; Takabe K
Ann Surg Oncol; 2018 Aug; 25(8):2323-2331. PubMed ID: 29770915
[TBL] [Abstract][Full Text] [Related]
15. Gamma-interferon-inducible lysosomal thiol reductase is upregulated in human melanoma.
Nguyen J; Bernert R; In K; Kang P; Sebastiao N; Hu C; Hastings KT
Melanoma Res; 2016 Apr; 26(2):125-37. PubMed ID: 26930048
[TBL] [Abstract][Full Text] [Related]
16. Novel reference genes in colorectal cancer identify a distinct subset of high stage tumors and their associated histologically normal colonic tissues.
Xu L; Luo H; Wang R; Wu WW; Phue JN; Shen RF; Juhl H; Wu L; Alterovitz WL; Simonyan V; Pelosof L; Rosenberg AS
BMC Med Genet; 2019 Aug; 20(1):138. PubMed ID: 31409279
[TBL] [Abstract][Full Text] [Related]
17. [Clinical relevance of common inhibitory immune checkpoint genes in esophageal squamous cell carcinoma].
Sun N; Li Y; He J
Zhonghua Yi Xue Za Zhi; 2018 Jun; 98(21):1703-1706. PubMed ID: 29925150
[No Abstract] [Full Text] [Related]
18. Evolutionary genetic algorithm identifies
Alderdice M; Craig SG; Humphries MP; Gilmore A; Johnston N; Bingham V; Coyle V; Senevirathne S; Longley DB; Loughrey MB; McQuaid S; James JA; Salto-Tellez M; Lawler M; McArt DG
NAR Genom Bioinform; 2021 Jun; 3(2):lqab016. PubMed ID: 33928242
[TBL] [Abstract][Full Text] [Related]
19. IFNγ-Dependent Tissue-Immune Homeostasis Is Co-opted in the Tumor Microenvironment.
Nirschl CJ; Suárez-Fariñas M; Izar B; Prakadan S; Dannenfelser R; Tirosh I; Liu Y; Zhu Q; Devi KSP; Carroll SL; Chau D; Rezaee M; Kim TG; Huang R; Fuentes-Duculan J; Song-Zhao GX; Gulati N; Lowes MA; King SL; Quintana FJ; Lee YS; Krueger JG; Sarin KY; Yoon CH; Garraway L; Regev A; Shalek AK; Troyanskaya O; Anandasabapathy N
Cell; 2017 Jun; 170(1):127-141.e15. PubMed ID: 28666115
[TBL] [Abstract][Full Text] [Related]
20. Identification of immune subtypes and prognosis of hepatocellular carcinoma based on immune checkpoint gene expression profile.
Xu D; Liu X; Wang Y; Zhou K; Wu J; Chen JC; Chen C; Chen L; Zheng J
Biomed Pharmacother; 2020 Jun; 126():109903. PubMed ID: 32113055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]